23-seleno-25-homotaurocholic acid has been researched along with Biliary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, JR; Eastwood, MA; Merrick, MV; Ross, HM | 1 |
| Fagioli, G; Furno, A; Malaguti, P; Pozzato, R; Sciarretta, G | 1 |
2 other study(ies) available for 23-seleno-25-homotaurocholic acid and Biliary Tract Diseases
| Article | Year |
|---|---|
Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT).
Topics: Administration, Oral; Animals; Bile; Biliary Tract Diseases; Body Burden; Cholic Acids; Drug Evaluation; Enterohepatic Circulation; Gallbladder; Humans; Ileum; Injections, Intravenous; Intestinal Absorption; Liver; Radioisotopes; Radionuclide Imaging; Rats; Taurocholic Acid | 1982 |
Scintigraphic evaluation of enterogastric reflux using 75Se-HCAT: methodology and first clinical observations.
Topics: Bile Reflux; Biliary Tract Diseases; Cholecystectomy; Duodenogastric Reflux; Eating; Gastrectomy; Humans; Postoperative Complications; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Selenium; Taurocholic Acid | 1987 |